For home parenteral nutrition, PICCs should be used for short-term therapy
the ONA take:
According to a new study published in the Journal of Parenteral and Enteral Nutrition (JPEN), researchers at Aalborg University in Aalborg, Denmark, have found that using a peripherally inserted central venous catheter (PICC) for one additional infusion day per week significantly reduced the amount of time before a first bloodstream infection.
For the study, researchers sought to examine whether environmental factors have an influence on the amount of time before a first infection in home parenteral nutrition patients.
Researchers enrolled 136 patients suffering from intestinal failure who were receiving home parenteral nutrition. There was a total of 169 tunneled vascular access devices and 126 PICCs used.
Researchers also found that using a tunneled vascular access device managed by a home care nurse increased the incidence of bloodstream infections.
The authors conclude that the PICCs should only be used for short-term therapy and when few infusion days per week are necessary.
Using a peripherally inserted central venous catheter significantly reduced the amount of time before a first bloodstream infection.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|